Navigation Links
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Date:5/20/2009

25 sites in the U.S. and will examine rates of device- and/or procedure-related major adverse events (MAE) at nine months. MAE are currently defined as death within 30 days, myocardial infarction (MI, or heart attack) occurring during related hospitalization, target vessel revascularization (TVR) through nine months and amputation of the treated limb through nine months.

The EPIC Stent is a next-generation product that builds on Boston Scientific's long-time leadership in the peripheral interventions market. The Company's peripheral product lines feature technologies used to diagnose and treat peripheral disease, including stents, balloon catheters, sheaths, wires, peripheral embolization solutions and vena cava filters. This advanced product portfolio offers physicians a range of peripheral stent indications, including the Carotid Wallstent(R) Endoprosthesis for carotid artery disease and the Express(R) SD Stent for renal artery disease.

The EPIC Nitinol Stent System is an investigational device and is limited by applicable law to investigational use only and is not available for sale in the U.S.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
2. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
3. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
4. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
5. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
6. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
7. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
8. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
9. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
10. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
11. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW ... for operable and inoperable solid tumor cancers, announced today that ... th Annual Phacilitate Immunotherapy Forum in Washington ... will take place on January 26 at 10:30 a.m. EST ...
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... RSB Spine, LLC, a medical device company focused on ... degenerative disc disease, today announced a 229% sales increase ... 2009, and a 46% increase sequentially.  Additionally, the company ... to expand U.S. operations. RSB Spine Chief ...
... Bionovo, Inc. (Nasdaq: BNVI ), a drug discovery ... and oncology, today announced that it has entered into definitive ... a registered direct offering through the sale of common stock ... 2,727,270 shares, at a price of $1.10 per share. In ...
Cached Medicine Technology:Bionovo to Raise $3 Million Through Registered Direct Offering 2Bionovo to Raise $3 Million Through Registered Direct Offering 3
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
(Date:1/22/2015)... a new blog post presenting a list of vehicles that cannot ... Some types of vehicles cannot be covered under an ordinary auto ... see if their vehicle qualifies for auto insurance coverage. , ... that cannot be covered by a plan. Clients have little options ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... be overcome to ensure therapeutic success, experts say , , MONDAY, ... an immune response in mice, a new study finds. If ... big roadblock to stem cell-based treatments, researchers say. , ... School of Medicine found that common anti-rejection medications could counter ...
... Competitive Analysis from, Thomson Reuters to Explore Various ... PHILADELPHIA, Aug. 18 Thomson Reuters, the,world,s leading ... announced the availability of the Pharma Matters reports,covering ... two years,ago, the quarterly Pharma Matters reports cover ...
... Battle on the Anniversary of His Heroism - ... One in Four Dogs Dies of Cancer - Leading Cause ... Cancer has claimed a hero police dog,and Morris Animal ... Lakewood Police Department in Colorado. MAF first honored Rocky six,years ...
... report findings on how genes impact efficacy of many commonly used ... ... Health,Solutions, Inc. (NYSE: MHS ), the nation,s leading pharmacy benefit ... into a,research partnership to study genetic testing and the impact of ...
... pay hundreds of dollars to get rid of the problem , , ... to pay a lot of money to be acne-free, according to ... , The study found the teens, on average, would pay about ... willing to pay much more to be acne-free ($100) than they,d ...
... to generate awareness of the problem , , MONDAY, Aug. 18 ... be transported to an official trauma center for immediate care ... was based on a review of a decade,s worth of ... that the difference in care first comes into play as ...
Cached Medicine News:Health News:Immune Response May Hinder Stem Cell Treatments 2Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 2Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 3Health News:Hero Police Dog Succumbs to Cancer - Morris Animal Foundation Honors 'Rocky' - Also Honored 'Rocky' Six Years Ago When He Was Shot 2Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 2Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 3Health News:Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 4Health News:Study Lets Teens Sound Off on Acne Therapies 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 3
... Pulse Oximeter monitors SpO2, pulse ... is designed to provide fast, ... The device rejects spontaneous motion ... operator of excess artifacts and ...
Rad-9™...
... Dolphin Medicals ONE™ technology is ... that uses a patented digital ... use an analog sensor. Dolphin ... digitize the signal in the ...
Immersion Oil, 21,000 cs...
Medicine Products: